Evommune, Inc. (EVMN)
12.46
-0.20
(-1.58%)
USD |
NYSE |
Sep 01, 14:29
Evommune Cash from Operations (Annual) : -76.44M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -76.44M |
| December 31, 2024 | -58.20M |
| Date | Value |
|---|---|
| December 31, 2023 | -29.97M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| MapLight Therapeutics, Inc. | -138.14M |
| Mineralys Therapeutics, Inc. | -142.42M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |